tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
NKTR is currently covered by 7 analysts with an average price target of $8.71. This is a potential upside of $7.64 (714.02%) from yesterday's end of day stock price of $1.07.
Nektar Therapeutics's activity chart (see below) currently has 124 price targets and 89 ratings on display. The stock rating distribution of NKTR is 50% HOLD, 37.5% SELL and 12.5% BUY.
Analysts average stock forecasts to be materialized ratio is 47.18% with an average time for these price targets to be met of 63.17 days.
Highest price target for NKTR is $3, Lowest price target is $3, average price target is $8.71.
Most recent stock forecast was given by JESSICA FYE from JPMORGAN on 20-Nov-2023. First documented stock forecast 28-Jul-2014.
Currently out of the existing stock ratings of NKTR, 4 are a HOLD (50%), 3 are a SELL (37.5%), 1 are a BUY (12.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
11 months 28 days ago
(20-Nov-2023)
5/8 (62.5%)
$6.02 (54.83%)
121
Buy
$2
1 years 8 days ago
(09-Nov-2023)
0/4 (0%)
$0.61 (43.88%)
Hold
$35
1 years 9 days ago
(09-Nov-2023)
0/6 (0%)
$17.89 (104.56%)
Hold
1 years 9 days ago
(08-Nov-2023)
0/3 (0%)
$1.26 (26.58%)
Hold
$1
$-0.07 (-6.54%)
$1.5
1 years 6 months 7 days ago
(10-May-2023)
3/3 (100%)
$0.25 (33.33%)
39
What is NKTR (Nektar Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on NKTR (Nektar Therapeutics) with a proven track record?
Which analyst has the most public recommendations on NKTR (Nektar Therapeutics)?
Which analyst is the currently most bullish on NKTR (Nektar Therapeutics)?
Which analyst is the currently most reserved on NKTR (Nektar Therapeutics)?
